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W e have developed a technique u t i l i s i n g sequential 0.1 M NaOH and 0.05% trypsin treatments which consistently reveals both 'C' and ' G ' bands in t h e same preparation. Furthermore, t h i s method shows a c l e a r e r delineation of t h e 'C' bands than i s usually seen by the standard ' C ' band methods. Thus, we have observed (1) consistent d i f f e r e n t i a t i o n of t h e ' C ' band of t h e #1 chromosome i n t o t h r e e d i s t i n c t bands (2) frequent s i m i l a r d i f f e r e n t i a t i o n of t h e ' C ' band of the #9 chromosome, (3) d i f f e r e n t i a t i o n of t h e Yq12 band i n t o a t l e a s t two bands.
Investigation of a p a t i e n t with 46,XX, inv(12)(p12qll) by t h i s technique indicates t h a t t h e functional cetromere does not occupy t h e whole of t h e #12 ' C ' band. A s i m i l a r phenomenon probably accounts f o r the 'inactivated centromere' observed with some translocations. Frigoletto. Harvard Med. Sch., Depts. of Neuro., Ped., and Obst., Mass. Gen. Hosp. E. K. ~h r i v e r -~t r . , and Boston Hosp. f o r Women, Boston. A number of inborn e r r o r s of metabolism (IEM) a r e not yet p r e n a t a l l y detectable. Perhaps most prominent among these i s phenylketonuria. I t i s possible t h a t i n t h e presence of an IEM, t h e affected f e t u s w i l l accumulate increased q u a n t i t i e s of one o r more of the metabolites and t h a t such increases w i l l be detectable by careful analyses of blood. In order t o make such determinations, however, adequate methods and normal values must be available. W e have q u a n t i t a t i v e l y examined t h e serum f r e e amino acids i n seven f e t u s e s of 12-20 weeks gestat i o n . In most of t h e examinations 0.1 m l . serum was used although a s l i t t l e a s 0.05 m l . was adequate. The serum was d i l u t e d and deproteinized i n 1.0 m l . 3% s u l f o s a l i c y l i c a c i d , centrifuged, and t h e e n t i r e supernatant applied t o an amino acid analyzer column. Qualitatively, amino acids were t h e same a s those i n postnatal blood o r amniotic f l u i d . Amino acid concentrations were generally 2-3 times g r e a t e r than corresponding concentrations as previously determined i n amnio t i c f l u i d o r maternal plasma of t h e same gestational time and of newborn plasma obtained on t h e f i r s t day of l i f e . Specific values i n u moles/ml. include Phe (.I74 t .049), Lys (.569 + .138) and Ala (.580 + .150), t h e l a t t e r two p a r t i c u l a r l y concentrated. Within t h e gestational range examined, t h e r e were no consistent differences i n t h e amino acid concentrations. MATERNAL PHENYLKETONURIA AND HYPERPHENYLALANINEMIA. A PROS-PECTIVE STUDY. Harvey L. Levy and Vivian E. Shih. S t a t e Lab I n s t . , Mass. Dept. Public Health, Harvard Med. Sch., and Mass. Gen. Hosp., Dept. of Neuro., Boston.
The possible e f f e c t s of increased blood phenylalanine concentrations on t h e f e t u s a r e of considerable importance, part i c u l a r l y since many g i r l s successfully t r e a t e d f o r phenylketonuria (PKU) w i l l s h o r t l y become of childbearing age. W e have studied prospectively 17 offspring of 8 women who have had varying degrees of hyperphenylalaninemia (HPHE). These women have been discovered as a r e s u l t of routine screening of an offspring, e i t h e r of cord blood or of newborn blood. None has received any d i e t a r y therapy. Group I includes 3 women with mild HPHE (blood Phe 3-6 mg%) and Group I 1 includes 2 women wlth intermediate HPHE (blood Phe >6-12 mg%; occasiona l mild phenylpyruvic aciduria). A l l 11 offspring a r e normal. Group I11 includes one woman with "atypical" PKU (blood Phe >12-15 mg%; moderate phenylpyruvic a c i d u r i a ) . Though she has a s l i g h t l y higher IQ than her non-PKU s i s t e r (78 vs. 71), her 3 offspring have consistently lower IQs than her s i s t e r ' s 3 offspring. Group IV includes two women with "classical" PKU. In one, who i s retarded (IQ 56), twin offspring a r e mentally retarded a t age 4 yr. (IQs 67 and 61) . In the o t h e r , who i s d u l l normal, t h e i n f a n t offspring i s developmentally slow a t age 1 year. Neither microcephaly nor congenital anomalies has been noted. I t would seem t h a t t h e degree of f e t a l brain damage from maternal PKU and HPHE may be proportional t o t h e maternal blood Phe level beginning a t >12 mg/100 m l . MRC ~e n e F i z s m M o n t r e a l Y C h i l d r e n ' s H -a n d M c G i l l u n i v e r s i t y , M o n t r e a l , C a n a d a . h o w e v e r s t e a d y -s t a t e d i s t r i b u t i o n r a t i o s & n e t u p t a k e r a t e s a r e d e p r e s s e d i n PRO/Re. T h e s e f i nd i n g s r e v e a l t h a t h y p e r p r o l i n u r i a c a n r e s u l t n o t o n l y f r o m s a t u r a t i o n o f a b s o r p t i o n , b u t a l s o f r o m e x a g g e r a t e d e f f l u x f r o m c e l l t o u r i n e b e c a u s e o f a b n o r m a l i n t r a r e n a i p r o a c c u m u l a t i o n .
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